Dublin, April 12, 2022 /PRNewswire/ — The “Global Telehealth & Telemedicine Market by Component (Software & Services (RPM, Real-Time), Hardware (Monitors)), Delivery (On-Premise, Cloud-Based), Application (Teleradiology, Telestroke, TeleICU), End User (Provider, Payer) & Region – Forecasts to 2027” report has been added to ResearchAndMarkets.com’s offering.
The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022.
The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19.
However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during the forecast period.
The software & services segment will grow at the highest rate during the forecast period
Based on components, the telehealth market is segmented into software & services and hardware segment. The software & segment accounted for the largest share of the telehealth market in 2021.
The large share of this segment is mainly due to the increasing adoption of telehealth and telemedicine across the globe. The hardware segment is projected to register the highest CAGR of 27.8% during the forecast period.
By delivery mode, the cloud-based segment accounted for the largest share of the telehealth market in 2021
Based on the mode of delivery, the global telehealth market is segmented into cloud-based and on-premise segments. The human pathology segment accounted for the largest share of the telehealth market in 2021.
The major factors driving the market for cloud-based delivery mode segments are the on-demand nature of the services, their easy scalability, and the costs-curtailing nature of cloud-based solutions.
The market in Asia Pacific is projected to witness the highest growth during the forecast period
Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of chronic conditions, the need to reduce healthcare expenditure, increasing overall and geriatric population.
Competitive landscape
Prominent players in the telehealth and telemedicine market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Teladoc Health (US), American Well (US), AMC Health (US), MDLIVE (US), Doctor on Demand (US), Medvivo (UK), and Iron Bow Technologies (US) among others.
Premium Insights
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Technology Analysis
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/ql3ri5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-telehealth–telemedicine-markets-2022-2027—opportunities-in-use-of-blockchain-ai-and-analytics–virtual-assistants-301523805.html
SOURCE Research and Markets
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…
BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…
PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…
STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…